UROLOGIX ORD SHS (ULGX) has a profit margin of -38.29%, below the sector sector average of 13.78%.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2015
Trailing 12 months ending Mar 2015
UROLOGIX ORD SHS (ULGX) currently reports a profit margin of -38.29% as of March 2015. That compares with -35.24% in the prior-year period — down 8.7% year over year. That is below the sector sector average of 13.78%. Use the charts on this page to explore UROLOGIX ORD SHS's profit margin history and peer comparisons.
UROLOGIX ORD SHS's profit margin decreased from -35.24% to -38.29% — a 8.7% year-over-year decrease (period ending March 2015). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
UROLOGIX ORD SHS's profit margin of -38.29% is lower than the its sector sector average of 13.78%. That is roughly 377.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but UROLOGIX ORD SHS's current -38.29% should be judged against industry norms (sector average: 13.78%) and against ULGX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -38.29%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.78%. From there, open related valuation or income-statement pages for UROLOGIX ORD SHS, and consider following ULGX for alerts when major investors trade the stock.